INTRODUCTION:

Cannabinoids, compounds emanated Cannabis sativa, have stretched interest for two together their curative and moving the mind so concerning produce intense hallucinatory effects. THC and CBD, particularly, have lied widely deliberate for their effect on the mind and material. Addiction, from egotistic drug-ensuing conduct, presents weighty society strength concerns¹². The ECS modulates main processes like stress answer and reward displaying, and allure dysregulation belongs to addiction³.

THC activates CB1 receptors in the ability’s reward pathways, toughening drug-out for behavior⁴. Chronic revealing can cause success CUD, obvious by retraction syndromes, and returned to use is still harm⁵. Conversely, CBD has presented potential to defeat dependence-affiliated administration through the tone of serotonin and dopamine systems⁶. Cannabinoids also ideas following additional drugs of abuse, maybe relieving relocation or angering dependency⁷.

Emerging studies on pot phytoconstituents and their checking characterizations improve the understanding of slant instruments and health-giving applications^8,9,10. This paper considers the neurobiology of cannabinoid-following craving, clarifies slant models, and considers friendships for impartial use.

Brain Mechanisms of Addiction:

Research over the last differing decades has elucidated the wit circuits and devices hidden in the practice of exercise. Drugs upset the mesolimbic dopamine plan, rising in the first tegmental domain (VTA) and jutting deep-rooted accumbens (NAc), powerful reward and reinforcement^11,13. With repeating use, control shifts from reward-enforced to habit-driven mind regions¹⁴.

Relapse remains a critical concern, enforced by drug re-revealing, stress, or referring to practices or policies that do not negatively affect the environment cues¹⁵. Animal models reveal relapse machines interfered by pathways containing the amygdala, hippocampus, and hypothalamus^16,18. Stress-implicit relapse uses corticotropin-seeping determinant and norepinephrine pathways, while advice-implicit relapse catches glutamatergic circuits from the hippocampus and amygdala to the VTA^19,21.

Properties of Addictive Substances Of working-class legendary bullets for weapon, about 100 have bag potential, mainly for that reason their effects on dopamine displaying and understanding reward systems²². Addictive elements stimulate VTA–NAc circuits, increase dopamine, improve ability stimulus reward, and draw out self-management and relapse practices in models^23-26.

THC and Its Addictive Potential

THC strengthens VTA–NAc dopamine displaying by increasing neuronal enticing and burst discharges in the VTA²⁷. This effect is prevented by CB1 antagonists, suggesting receptor-particular action²⁸. THC boosts NAc dopamine levels, equal to opioids, exciting, and stimulants²⁹.

THC decorates mind stimulus reward (BSR), induces prepared place inclination (CPP), and supports self-management, all hallmarks of addiction^30,32. THC acts on two together the VTA and NAc, improving drug-ensuing through dopamine overflow³³.

Cannabis Addiction in Humans:

Human studies show agreeable pot self-presidency and various withdrawal diseases holding temper, yearning, and sleep disturbance^34,36. Cannabis use guides knowledgeable deficits, turbine degeneration, and bred risk of insane disorders^37,39.

The Diagnostic and Statistical Manual sees grass confidence as an impartial condition, following conclusive tests to some extent courage, withdrawal, reopened use although harm and significant occasion disappeared taking advantage of the drug⁴⁰. Dependence is an unusual concern in teenagers, belonging to feeble academic acts, co-use of supplementary bodies, and praised risk for schizophrenia⁴¹.

Other Cannabinoids: CBD and THCV:

CBD antagonizes CB1 receptor venture and modulates bent-following practices. Studies show CBD attenuates drug-following and clue-persuaded relapse in animal models and reduces THC’s advantageous accouterments in humans⁴². THCV, which acts as a CB1 invader and CB2 agonist, can further hold healing potential for acting addiction⁴³.

Research Method:

This study engages an orderly review method to examine the friendship between cannabinoids and enslavement. Data were calm from peer-reviewed journals, dispassionate troubles, and meta-studies written in the last decade. The additional tests contained studies on the belongings of cannabinoids in addiction-connected nature, neurobiological devices, and healing applications. Key variables in the way that portion of drug or other consumable, type of cannabinoid, and event valuable were analyzed. Statistical forms were used to combine verdicts and judge the meaning of observed currents.

RESULT:

The results concerning this study signify a two-fold role of cannabinoids in craving. THC, the affecting the mind to produce vivid visions component of marijuana, was established to reinforce habit-forming actions in a few things, specifically when consumed in extreme doses or over extended periods. Conversely, CBD has shown the potential to lower addictive trends by modulating stress answers and reward pathways in intelligence. Clinical troubles reported assorted effects, accompanying few professed the efficacy of CBD in directing wealth use disorders, while possible choice emphasize its restricted belongings under certain environments. The neurobiological dossier revealed that cannabinoids communicate accompanying the endocannabinoid whole, doing pathways associated with reward, ambition, and retraction.

Table 1: Summary of Cannabinoid Effects on Addiction

Cannabinoid	Effect on Addiction	Mechanism of Action	Evidence Level
THC	Reinforces addictive behavior	Activates CB1 receptors in reward pathways	High
CBD	Reduces addictive tendencies	Modulates stress responses and reward pathways	Moderate to High

DISCUSSION:

The judgments climax the intricate part of cannabinoids in craving. THC’s potential to infuriate hang-ups underlines the need for careful management of allure use, specifically in sports contexts. In contrast, CBD’s talent to lighten enslavement-accompanying behaviors presents a hopeful path for a healing attack. The consideration explores the fundamental devices, to a degree CBD’s timbre of the hypothalamic-pituitary-adrenal (HPA) axis, and allure belongings on serotonin and dopamine levels. Furthermore, the study stresses the significance of personalized cure approaches, taking everything in mind individual instability in cannabinoid absorption and answer. Limitations of existing studies, to a degree narrow sample sizes and lack of an unending dossier, are also focused on.

Source: Pertwee, R. G. (2006). Cannabinoid pharmacology: the first 66 years. British Journal of Pharmacology, 147(1), S163-S171.

CONCLUSION:

Cannabinoids present both risks and therapeutic opportunities in the context of addiction. THC exhibits addiction-promoting properties, while CBD may offer benefits in managing wealth use disorders. Further research is essential to evaluate long-term effects, refine treatment strategies, and inform regulatory policies.

ACKNOWLEDGMENT:

The finishing touch of this studies undertaking may want to no longer have been possible with out the contributions and steering of many individuals and organizations. we're deeply grateful to all folks that performed a role within the success of this assignment we may additionally need to thank My Mentor [. Naweed Imam Syed Prof. department of cell Biology on the college of Calgary and Dr. Sadaf Ahmed Psychophysiology Lab college of Karachi for her useful entry and steerage during the studies. Their insights and facts had been instrumental in shaping the direction of this undertaking.

DECLARATION OF INTEREST:

I at this moment claim that：

I don't have any pecuniary or other non-public interest, direct or indirect, in any depend that raises or may moreover enhance a battle with my responsibilities as a manager of my administrative center control.

CONFLICTS OF INTEREST:

The authors declare that they have got no conflicts of interest.

REFERENCES:

1. Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse energy belongings of pot use. N Engl J Med. 2014; 370(23): 2219–27.

2. Hall W, Degenhardt L. The antagonistic strength belongings of incessant marijuana use. Drug Test Anal. 2014; 6(1–2): 39–45.

3. Lu HC, Mackie K. An influx to the inside cannabinoid arrangement. Biol Psychiatry. 2016;79(7):516–25.

4. Gardner EL. A new view of marijuana resistance and dependence. Drug Alcohol Depend. 2002;67(2):91–6.

5. Budney AJ, Hughes JR. The marijuana retraction condition. Curr Opin Psychiatry. 2006;19(3):233–8.

6. Morgan CJA, Das RK, Joye A, Curran HV, Kamboj SK. Cannabidiol reduces smoke devouring in crop smokers: preliminary judgments. Addict Behav. 2013; 38(9): 2433–6.

7. Wiese B, Wilson-Poe AR. Emerging evidence for marijuana’ duty in opioid use disorder. Cannabis Cannabinoid Res. 2018; 3(1): 179–89.

8. Andre CM, Hausman JF, Guerriero G. Cannabis sativa: The plant of the thousand and individual fragments. Front Plant Sci. 2016; 7:19.

9. ElSohly MA, Slade D. Chemical elements of pot: the complex combination of organic cannabinoids. Life Sci. 2005; 78(5): 539–48.

10. Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers. 2007;4(8):1770–804.

11. Koob GF, Volkow ND. Neurocircuitry of hang-up. Neuropsychopharmacology. 2010;35(1):217–38.

12. Nestler EJ. Is skill an ordinary microscopic road for enslavement? Nat Neurosci. 2005;8(11):1445–9.

13. Wise RA, Koob GF. The happening and sustenance of drug inclination. Neuropsychopharmacology. 2014;39(2):254–62.

14. veritt BJ, Robbins TW. Neural methods of support for drug addiction: from conduct to tendencies to drive. Nat Neurosci. 2005;8(11):1481–9.

15. Sinha R. Chronic stress, dependence on illegal substances, and exposure to inclination. Ann N Y Acad Sci. 2008; 1141:105–30.

16. Kalivas PW, O’Brien C. Drug inclination as a study of plants of produced neuroplasticity. Neuropsychopharmacology. 2008;33(1):166–80.

17. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J. The restoration model of drug relapse: past, methods and important judgments. Psychopharmacology (Berl). 2003; 168(1–2): 3–20.

18. Lu L, Shepard JD, Hall FS, Shaham Y. Effects of incidental framework and retraction on trained suggestion-inferred drug-pursuing conduct in rats. J Neurosci. 2003; 23(30): 10539–45.

19. Erb S, Salmaso N, Rodaros D, Stewart J. A part of the CRF-holding road from the main nucleus of the amygdala to the bed core of the stria terminalis in stress-persuaded restoration of sugar pursuing. Psychopharmacology (Berl). 2001;158(4):360–5.

20. Koob GF. The belief in the bad outcome of excitement: the craving outlook. Eur J Pharmacol. 2015; 753:73–87.

21. Bossert JM, Poles GC, Wihbey KA, Koya E, Shaham Y. Differential belongings of the barrier of dopamine D1-offspring receptors in core accumbens gist or covering on restoration of dope pursuing in rats. J Neurosci. 2007;27(46):12655–63.

22. Di Chiara G, Imperato A. Drugs persecutes by persons a suggestion of choice increase synaptic dopamine concentrations in the mesolimbic arrangement of freely affecting rats. Proc Natl Acad Sci U S A. 1988;85(14):5274–8.

23. Volkow ND, Wang GJ, Fowler JS, Tomasi D. Addiction circuits in the human intellect. Annu Rev Pharmacol Toxicol. 2012; 52:321–36.

24. Berridge KC, Robinson TE. Liking, inadequate, and the incentive-sensitization belief of inclination. Am Psychol. 2016;71(8):670–9.

25. Boileau I, Assaad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M, and others. Alcohol advances dopamine release in the human core accumbens. Synapse. 2003;49(4):226–31.

26. Le Foll B, Goldberg SR. Cannabinoid CB1 receptor antagonists as hopeful new cures for dependence on illegal substances. J Pharmacol Exp Ther. 2005;312(3):875–83.

27. Cheer JF, Wassum KM, Sombers LA, Heien MLAV, Ariansen JL, Aragona BJ, and others. Phasic dopamine release induced by persecuted entities demands cannabinoid receptor incitement. J Neurosci. 2007;27(4):791–5.

28. Solinas M, Goldberg SR, Piomelli D. The endocannabinoid scheme in intelligence reward processes. Br J Pharmacol. 2008;154(2):369–83.

29. Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and dope incitement of mesolimbic dopamine broadcast by an average mu1 opioid receptor system. Science. 1997;276(5321):2048–50.

30. Braida D, Pozzi M, Parolaro D, Sala M. Intracerebroventricular Δ9-tetrahydrocannabinol induces trained place option in rats. Eur J Pharmacol. 2001;416(1–2):75–9.

31. Panlilio LV, Goldberg SR, Justinova Z. Cannabinoid abuse and a habit of activity: dispassionate and preclinical judgments. Clin Pharmacol Ther. 2015;97(6):616–27.

32. Fattore L, Fadda P, Fratta W. Sex distinctnesses in the self-administration of cannabinoids and different drugs of abuse. Psychoneuroendocrinology. 2009;34(Suppl 1): S227–36.

33. Maldonado R, Valverde O, Berrendero F. Involvement of the endocannabinoid order in drug inclination. Trends Neurosci. 2006;29(4):225–32.

34. Budney AJ, Vandrey RG, Hughes JR, Moore BA, Bahrenburg B. Oral plain bordering a river-9-tetrahydrocannabinol restrain marijuana removal manifestations. Drug Alcohol Depend. 2007;86(1):22–9.

35. Vandrey RG, Budney AJ, Moore BA, Hughes JR. A cross-study contrasting of marijuana and cigarette retraction. Am J Addict. 2005;14(1):54–63.

36. Allsop DJ, Copeland J, Norberg MM, Fu S, Molnar A, Lewis J, and others. Quantifying the dispassionate meaning of marijuana retraction. PLoS One. 2012;7(9): e44864.

37. Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RS, and others. Persistent marijuana consumers show neuropsychological decline from teens to middle years. Proc Natl Acad Sci U S A. 2012;109(40): E2657–64.

38. Yücel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, and others. Regional mind anomalies guide long-term burdensome marijuana use. Arch Gen Psychiatry. 2008;65(6):694–701.

39. Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, and others. Cannabis use and risk of schizophrenic or concerning feelings and intuition insane energy consequences: an orderly review. Lancet. 2007;370(9584):319–28.

40. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.

41. Rubino T, Parolaro D. Long lasting results of marijuana uncovering in adulthood. Mol Cell Endocrinol. 2008;286(1–2 Suppl 1):S108–13.

42. Gonzalez-Cuevas G, Martin-Fardon R, Kerr TM, Stouffer DG, Parsons LH, Koob GF, and others. Unique situation potential of cannabidiol for the stop of relapse to dependence on illegal substance: preclinical evidence of law. Neuropsychopharmacology. 2018;43(10):2036–45.

43. Pertwee RG. Targeting the endocannabinoid plan accompanying cannabinoid receptor agonists: pharmacological approaches and healing potential. Philos Trans R Soc Lond B Biol Sci. 2012;367(1607):3353–63.

Received on 11.12.2024 Revised on 06.03.2025

Accepted on 14.05.2025 Published on 04.10.2025

Available online from October 10, 2025

Asian J. Res. Pharm. Sci. 2025; 15(4):395-398.

DOI: 10.52711/2231-5659.2025.00058

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.